An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense
Irina G. Obrosova(Louisiana State University System), Martin J. Stevens(Heart of England NHS Foundation Trust), Lamia Fathallah(University of Michigan), Carol Van Huysen(University of Michigan), Douglas A. Greene(Michigan Medicine), Xianghui Cao(University of Michigan)
Cited by 211
Related Papers
Diabetic neuropathy and oxidative stress
|Diabetes/Metabolism Research and Reviews|2006|286
Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
|European Journal of Pharmacology|1999|235
Obstructive Sleep Apnea and Diabetic Neuropathy: A Novel Association in Patients with Type 2 Diabetes
|American Journal of Respiratory and Critical Care Medicine|2012|194
Cardiovascular autonomic neuropathies as complications of diabetes mellitus
|Nature Reviews Endocrinology|2012|179
Methods of investigation for cardiac autonomic dysfunction in human research studies
|Diabetes/Metabolism Research and Reviews|2011|173